摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-环己基-5-氧代戊酸乙酯 | 16076-61-2

中文名称
5-环己基-5-氧代戊酸乙酯
中文别名
——
英文名称
ethyl 5-cyclohexyl-5-oxopentanoate
英文别名
5-cyclohexyl-5-oxopentanoic acid ethyl ester;Aethyl-5-cyclohexyl-5-oxo-pentanoat;Ethyl 5-cyclohexyl-5-oxovalerate
5-环己基-5-氧代戊酸乙酯化学式
CAS
16076-61-2
化学式
C13H22O3
mdl
——
分子量
226.316
InChiKey
ZKWVCHISJOCZTP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    105-106 °C(Press: 0.45 Torr)
  • 密度:
    1.011±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2918300090

SDS

SDS:edb7ae9d13a80ebb2ff32d166d871df2
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SmCp<sup>R</sup><sub>2</sub>-mediated cross-coupling of allyl and propargyl ethers with ketoesters and a telescoped approach to complex cycloheptanols
    作者:Mateusz P. Plesniak、Xavier Just-Baringo、Fabrizio Ortu、David P. Mills、David J. Procter
    DOI:10.1039/c6cc07318b
    日期:——
    A highly regio- and diastereoselective cross-coupling of allyl/propargyl ethers and [small beta]-ketoesters, mediated by SmCpR2 reagents, delivers decorated [small delta]-lactones. Screening of the Cp ligands on Sm(II) was employed to achieve high...
    由SmCpR2试剂介导的烯丙基/炔丙基醚与小β-酮酸酯的高度区域选择性和非对映选择性交叉偶联可产生修饰的小δ-内酯。通过筛选Sm(II)上的Cp配体来实现高...
  • 2,3,5-trisubstituted thiophene compounds and uses thereof
    申请人:Barnes David
    公开号:US09040690B2
    公开(公告)日:2015-05-26
    The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了公式I的化合物:发明化合物的制备方法及其治疗用途。本发明还提供了药理活性剂的组合和制药组合物。
  • 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof
    申请人:Barnes David
    公开号:US20130123252A1
    公开(公告)日:2013-05-16
    The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了一种I式化合物,一种制造该化合物的方法及其治疗用途。本发明还提供了一种药理活性剂的组合物和一种制药组合物。
  • Carbonylation of mixed trialkylboranes containing substituents as a synthetic route to unsymmetrical ketones with such functional substituents. Route for the conversion of olefins, RCH:CH2, into the corresponding carboxylic acids, RCH2CH2CO2H
    作者:Herbert Charles. Brown、George W. Kabalka、Michael W. Rathke
    DOI:10.1021/ja00993a054
    日期:1967.8
  • Design and synthesis of lactam–thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors
    作者:David Barnes-Seeman、Carri Boiselle、Christina Capacci-Daniel、Rajiv Chopra、Keith Hoffmaster、Christopher T. Jones、Mitsunori Kato、Kai Lin、Sue Ma、Guoyu Pan、Lei Shu、Jianling Wang、Leah Whiteman、Mei Xu、Rui Zheng、Jiping Fu
    DOI:10.1016/j.bmcl.2014.06.031
    日期:2014.8
    Herein we report the successful incorporation of a lactam as an amide replacement in the design of hepatitis C virus NS5B Site II thiophene carboxylic acid inhibitors. Optimizing potency in a replicon assay and minimizing potential risk for CYP3A4 induction led to the discovery of inhibitor 22a. This lead compound has a favorable pharmacokinetic profile in rats and dogs. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多